Management of "brittle" diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.

Abstract

The implanted programmable intraperitoneal insulin pump may be of value in the management of patients with "brittle" diabetes in whom other attempts at glycaemic control have failed.